See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend
|
|
  Company Name
|
CMP
|
Price
Change (%) |
Market
Cap (Cr) |
52Week
High |
52Week
Low |
ROE(%)
|
P/E
|
P/BV
|
EV/
EBITDA |
5Y Sales
Gr.(%) |
5Y Profit
Gr.(%) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Q
V+
PT
|
407 | 2.96% | 15,959 Small Cap |
678 07 Jan, 26 |
376 30 Jul, 26 |
8.49 | 69.75 | 3.42 | 19.04 | 9.45 | 1.26 |
|
|
| 2 |
Q
V
PT
|
1,120 | 1.01% | 1,10,603 Mid Cap |
1,206 13 Aug, 26 |
836 02 Apr, 26 |
17.64 | 24.51 | 4.10 | 13.78 | 13.52 | 14.72 |
|
|
| 3 |
Q
V+
PT
|
1,620 | 0.84% | 92,429 Mid Cap |
1,682 13 Aug, 26 |
1,017 02 Sep, 25 |
10.64 | 35.65 | 3.94 | 24.58 | -6.73 | -4.90 |
|
|
| 4 |
Q
V
PT
|
26,246 | 0.57% | 55,453 Mid Cap |
32,950 21 Aug, 25 |
25,164 27 Apr, 26 |
34.24 | 34.34 | 10.71 | 23.54 | 9.96 | 17.33 |
|
|
| 5 |
Q
V+
PT
|
1,910 | 0.54% | 48,210 Mid Cap |
1,945 17 Aug, 26 |
1,253 24 Oct, 25 |
16.05 | 38.76 | 5.77 | 23.59 | 7.35 | 1.36 |
|
|
| 6 |
Q
V
PT
|
414 | 0.47% | 67,160 Mid Cap |
447 16 Jul, 26 |
337 30 Sep, 25 |
0.71 | 687.41 | 2.46 | 115.72 | 2.96 | -18.61 |
|
|
| 7 |
Q
V+
PT
|
1,901 | -0.01% | 4,56,114 Large Cap |
2,048 31 Jul, 26 |
1,547 26 Sep, 25 |
14.80 | 37.71 | 5.27 | 22.34 | 11.78 | 14.41 |
|
|
| 8 |
Q
V
PT
|
5,398 | -0.05% | 64,565 Mid Cap |
5,933 13 Jan, 26 |
5,085 02 Apr, 26 |
16.67 | 30.27 | 4.43 | 20.48 | 6.01 | 5.86 |
|
|
| 9 |
Q
V
PT
|
997 | -0.17% | 97,201 Mid Cap |
1,259 22 Aug, 25 |
904 07 Apr, 26 |
14.68 | 66.72 | 8.90 | 40.00 | 27.27 | 155.29 |
|
|
| 10 |
Q
V+
PT
|
8,550 | -0.43% | 2,27,958 Large Cap |
8,671 12 Aug, 26 |
5,638 29 Sep, 25 |
15.58 | 77.93 | 12.91 | 50.81 | 8.67 | 4.44 |
|
|
| 11 |
Q
V+
PT
|
1,815 | -0.46% | 98,499 Mid Cap |
1,870 10 Aug, 26 |
823 26 Sep, 25 |
17.86 | 90.09 | 17.47 | 48.28 | 7.19 | -2.25 |
|
|
| 12 |
Q
V
PT
|
2,193 | -0.46% | 1,00,733 Mid Cap |
2,530 16 Jul, 26 |
1,882 02 Sep, 25 |
26.43 | 18.22 | 4.23 | 10.08 | 13.02 | 32.37 |
|
|
| 13 |
Q
V+
PT
|
1,175 | -0.54% | 98,604 Mid Cap |
1,414 29 Jun, 26 |
1,080 23 Jul, 26 |
10.90 | 30.60 | 2.58 | 15.69 | 12.09 | 15.75 |
|
|
| 14 |
Q
V
PT
|
2,372 | -0.55% | 98,500 Mid Cap |
2,670 22 Sep, 25 |
1,910 23 Mar, 26 |
13.55 | 45.17 | 5.83 | 28.68 | 13.54 | 13.36 |
|
|
| 15 |
Q
V+
PT
|
8,659 | -0.70% | 1,25,380 Large Cap |
9,327 03 Aug, 26 |
6,680 28 Jan, 26 |
16.08 | 79.81 | 12.16 | 44.91 | 14.92 | 0.00 |
|
|
| 16 |
Q
V+
PT
|
904 | -0.79% | 68,762 Mid Cap |
1,105 13 Oct, 25 |
767 02 Apr, 26 |
2.28 | 303.92 | 7.41 | 126.99 | 23.15 | 0.00 |
|
|
| 17 |
Q
V
PT
|
1,426 | -0.80% | 1,16,141 Mid Cap |
1,672 23 Oct, 25 |
1,166 02 Apr, 26 |
11.57 | 34.46 | 3.30 | 18.64 | 8.01 | 10.07 |
|
|
| 18 |
Q
V+
PT
|
2,306 | -0.82% | 65,617 Mid Cap |
2,471 29 Apr, 26 |
1,794 28 Oct, 25 |
27.89 | 36.50 | 5.99 | 12.17 | 9.19 | 22.19 |
|
|
| 19 |
Q
V+
PT
|
214 | -1.36% | 28,824 Small Cap |
218 10 Aug, 26 |
133 23 Mar, 26 |
6.31 | 41.16 | 3.52 | 22.09 | 10.23 | -6.64 |
|
|
| 20 |
Q
V+
PT
|
4,881 | -2.29% | 1,89,990 Large Cap |
5,250 03 Aug, 26 |
3,480 14 Oct, 25 |
29.04 | 87.11 | 21.17 | 39.75 | 11.80 | 13.74 |
|
Nifty Healthcare Index - Today's Top Gainers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 407.05 | 2.96% | |
| 1,120 | 1.01% | |
| 1,619.95 | 0.84% | |
| 26,245.55 | 0.57% | |
| 1,910.45 | 0.54% |
Nifty Healthcare Index - Today's Top Losers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 4,880.50 | -2.29% | |
| 213.55 | -1.36% | |
| 2,306 | -0.82% | |
| 1,426.20 | -0.80% | |
| 903.60 | -0.79% |
Thematic Indices:
Nifty Aditya Birla Group Nifty Core Housing Nifty Commodities Nifty CPSE Nifty Financial Services Nifty Energy Nifty Housing Nifty India Consumption Nifty India Defence Nifty India Digital Nifty India Manufacturing Nifty Infrastructure Nifty Mahindra Group Nifty Midcap Liquid 15 Nifty MNC Nifty Mobility Nifty PSE Nifty Non-cyclical Consumer Nifty Services Sector Nifty Shariah 25 Nifty Tata Group Nifty Tata Group 25% Cap Nifty Transportation & Logistics Nifty100 Liquid 15 Nifty50 Shariah Nifty500 Shariah NIFTY SME EMERGE Nifty100 Esg NIFTY100 Enhanced ESG Nifty100 ESG Sector LeadersStrategy Indices:
Nifty100 Equal Weight Nifty100 Low Volatility 30 Nifty 50 Arbitrage Nifty200 Momentum 30 NIFTY100 Alpha 30 Nifty Alpha 50 Nifty Alpha Low-volatility 30 Nifty Alpha Quality Low-volatility 30 Nifty Alpha Quality Value Low-volatility 30 Nifty Growth Sectors 15 Nifty High Beta 50 NIFTY100 Quality 30 NIFTY Midcap150 Quality 50 Nifty Quality Low Volatility 30 Nifty50 Dividend Points Nifty50 Equal Weight Nifty50 Value 20 Nifty500 Value 50 Nifty200 Quality 30You can use different criterias to arrive at the list of best stocks in the Nifty Healthcare Index company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Healthcare Index companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 26,246 | 55,453 | 34.34 | 10.71 | 23.54 | 34.24 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,881 | 1,89,990 | 87.11 | 21.17 | 39.75 | 29.04 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,306 | 65,617 | 36.50 | 5.99 | 12.17 | 27.89 |
| Lupin Ltd. (M) | Somewhat Good | 2,193 | 1,00,733 | 18.22 | 4.23 | 10.08 | 26.43 |
| Laurus Labs Ltd. (M) | Very Good | 1,815 | 98,499 | 90.09 | 17.47 | 48.28 | 17.86 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,815 | 98,499 | 108 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,620 | 92,429 | 53.58 |
| Divis Laboratories Ltd. (L) | Very Good | 8,550 | 2,27,958 | 43.00 |
| Ipca Laboratories Ltd. (M) | Very Good | 1,910 | 48,210 | 38.81 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,881 | 1,89,990 | 36.36 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| Max Healthcare Institute Ltd. (M) | N/A | 997 | 97,201 | 66.72 | 8.90 | 40.00 | 27.27 |
| Fortis Healthcare Ltd. (M) | Not Good | 904 | 68,762 | 304 | 7.41 | 127 | 23.15 |
| Apollo Hospitals Enterprise Ltd. (L) | Somewhat Good | 8,659 | 1,25,380 | 79.81 | 12.16 | 44.91 | 14.92 |
| Mankind Pharma Ltd. (M) | Very Good | 2,372 | 98,500 | 45.17 | 5.83 | 28.68 | 13.54 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,120 | 1,10,603 | 24.51 | 4.10 | 13.78 | 13.52 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Max Healthcare Institute Ltd. (M) | N/A | 997 | 97,201 | 66.72 | 8.90 | 40.00 | 155 |
| Lupin Ltd. (M) | Somewhat Good | 2,193 | 1,00,733 | 18.22 | 4.23 | 10.08 | 32.37 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,306 | 65,617 | 36.50 | 5.99 | 12.17 | 22.19 |
| Abbott India Ltd. (M) | Very Good | 26,246 | 55,453 | 34.34 | 10.71 | 23.54 | 17.33 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,175 | 98,604 | 30.60 | 2.58 | 15.69 | 15.75 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
|
Name of the IA registered
with SEBI: |
The Alchemists Ark Pvt. Ltd. |
|
Logo:
|
|
|
Trade/Brand
Name of IA: |
MoneyWorks4Me Investment Advisers |
|
Brand Logo:
|
 |
|
SEBI Registration Number:
|
INA000013323 Validity – May 16, 2019 – Perpetual |
|
Registration:
|
Non-Individual |
|
BSE Enlistment No:
|
1187 |
|
Address:
|
B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045 |
|
Compliance Officer
Details: |
Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com |
Telephone: +919860359463 Address: Same as IA |
|
Grievance Officer
Details: |
Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com |
Telephone: +919860919463 Address: Same as IA |
|
Principal Officer
Details: |
Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com |
Telephone: +919175899463 Address: Same as IA |
|
Standard Warning:
|
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. |
|
|
Disclaimer:
|
Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. |
|
